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Abstract
Introduction: We investigated whether treatment with terlipressin during recovery from hypotension due to
haemorrhagic shock (HS) is effective in restoring cerebral perfusion pressure (CPP) and brain tissue markers of water
balance, oxidative stress and apoptosis.
Methods: In this randomised controlled study, animals undergoing HS (target mean arterial pressure (MAP) 40 mmHg
for 30 minutes) were randomised to receive lactated Ringer’s solution (LR group; n =14; volume equal to three times
the volume bled), terlipressin (TERLI group; n =14; 2-mg bolus), no treatment (HAEMO group; n =12) or sham (n =6).
CPP, systemic haemodynamics (thermodilution technique) and blood gas analyses were registered at baseline, shock
and 5, 30, 60 (T60), 90 and 120 minutes after treatment (T120). After the animals were killed, brain tissue samples were
obtained to measure markers of water balance (aquaporin-4 (AQP4)), Na+-K+-2Cl− co-transporter (NKCC1)), oxidative
stress (thiobarbituric acid reactive substances (TBARS) and manganese superoxide dismutase (MnSOD)) and apoptotic
damage (Bcl-x and Bax).
Results: Despite the HS-induced decrease in cardiac output (CO) and hyperlactataemia, resuscitation with terlipressin
recovered MAP and resulted in restoration of CPP and in cerebral protection expressed by normalisation of AQP4,
NKCC1, TBARS and MnSOD expression and Bcl-x/Bax ratio at T60 and T120 compared with sham animals. In the LR
group, CO and blood lactate levels were recovered, but the CPP and MAP were significantly decreased and TBARS
levels and AQP4, NKCC1 and MnSOD expression and Bcl-x/Bax ratio were significantly increased at T60 and T120
compared with the sham group.
Conclusions: During recovery from HS-induced hypotension, terlipressin was effective in normalising CPP and cerebral
markers of water balance, oxidative damage and apoptosis. The role of this pressor agent on brain perfusion in HS
requires further investigation.
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Introduction
Haemorrhagic shock is the leading cause of early death
in trauma patients [1]. During the pre-hospital period,
haemorrhage contributes to death in 33% to 56% of
cases, and it is the most common cause of death among
those found dead upon the arrival of emergency medical
services personnel [2]. Neurological signs such as altered
mental state, which typically includes obtundation,
disorientation, confusion, agitation and irritability, cannot
be neglected, because cerebral hypoperfusion is a conse-
quence in patients experiencing bleeding-associated
hypotension [3-5]. In addition, animal studies of haemor-
rhagic shock have shown that cerebral ischaemia with
cell damage begins at the onset of the haemodynamic
impairment [6-8].
Under hypotensive conditions such as those in haemor-
rhagic shock, cerebral perfusion pressure (CPP) is
sustained below the lower limits of autoregulation
[8], which is detrimental to brain tissue oxygenation
[5,7,9]. Cerebral ischaemia has been associated with
dysregulation of aquaporin-4 (AQP4) and Na+-K+-2Cl −
co-transporter (NKCC1) in the astrocytes [9,10] and Bcl-2
related apoptotic proteins in the neurons [11]. Oxidative
stress is implicated in the neuronal apoptosis that occurs
in haemorrhagic shock. It has been shown to accompany
increased lipid peroxidation within the brain, as reflected
by changes in the levels of thiobarbituric acid reactive
substances (TBARS) and changes in the expression of
antioxidant enzymes such as manganese superoxide
dismutase (MnSOD) [12].
Standard resuscitation practice for haemorrhagic shock
mandates use of high-volume crystalloids. However, such
therapy can result in adverse effects such as interstitial
oedema in the gut and cellular oedema in the heart [13],
increases in the inflammatory cytokine profile [14] and
increased intracranial pressure (ICP) [8]. Crystalloids may
also fail to recover CPP and oxygenation within the brain
[8,15]. Terlipressin is a synthetic, long-acting (4 to 6 hours)
analogue of vasopressin. The structure of terlipressin con-
tains a peptide that represents the natural hormone lysine
vasopressin, the innate vasopressin analogue in pigs. Its
structure is very similar to human arginine vasopressin,
but the synthetic drug is characterised by a more specific
V1 agonistic effect (V1:V2 ratio =2.2:1) compared with
arginine-vasopressin (V1:V2 ratio =1:1). Terlipressin has
been studied as a vasoactive drug in the management of
catecholamine-resistant arterial hypotension in septic
shock [16], liver failure [17] and acute gastrointestinal
bleeding [18]. The effects of terlipressin consist of
vasoconstrictive activity on vascular smooth muscle
cells and a pronounced vasoconstriction within the
splanchnic circulation that has been shown to redistribute
blood flow to recover perfusion pressure to organs such as
the liver, kidney and brain [19,20] and to increase survival
rates in animal studies of haemorrhagic shock [14,21]. It
has been reported that terlipressin can improve CPP in
patients with acute liver failure [17], septic shock [22] and
traumatic brain injury with catecholamine-resistant
shock [23]. However, the effects of terlipressin on
cerebral haemodynamics during early treatment for
haemorrhagic shock remain unclear, and no data are
available comparing the effects of resuscitation with
terlipressin with those of standard fluid.
We hypothesised that early recovery of haemorrhagic
shock-induced hypotension with terlipressin could restore
CPP and improve oxygenation of the brain. Therefore, the
purpose of the present study was to investigate the effects
of early administration of terlipressin on CPP and brain
tissue oxygen pressure (PbtO2), as well as on the regula-
tion of tissue markers of water balance (that is, AQP4 and
NKCC1), oxidative stress (that is, TBARS and MnSOD)
and apoptosis (that is, Bax and Bcl-x) within the brain in a
porcine model of haemorrhagic shock.
Materials and methods
Ethical approval
This prospective randomised experimental study was
approved by the Comissão de Ética em Pesquisa of
the Hospital das Clínicas at Faculdade de Medicina of
Universidade de São Paulo (067/11 and 280/13).
Surgical preparation and monitoring
Female Large White pigs (n =46) weighing 20 to 30 kg
were fasted for 12 hours with free access to water
before the experiments. The animals were premedicated
with ketamine (5 mg/kg intramuscular) and midazolam
(0.25 mg/kg intramuscular), and anaesthesia was induced
with propofol (7 mg/kg intravenous). After endotracheal
intubation, anaesthesia was maintained with isoflurane
vaporized in 40% oxygen, and the pigs were ventilated
(Fabius GS Premium; Dräger, Lübeck, Germany) with a
tidal volume of 8 ml/kg and positive end-expiratory pres-
sure of 5 cmH2O. The respiratory rate was adjusted to
maintain normocapnia (partial pressure of carbon dioxide
in arterial blood (PaCO2) between 35 and 45 mmHg).
Lactated Ringer’s solution (4 ml/kg/hr) and pancuronium
(0.3 mg/kg/hr) were administered continuously through-
out the experiments. Body temperature was maintained
at 38°C using a heated mat (Medi-Therm II; Gaymar
Industries, Orchard Park, NY, USA).
Both femoral arteries were catheterised for measurement
of mean arterial pressure (MAP) and withdrawal of blood
to induce haemorrhagic shock, respectively. Another
catheter was inserted into the right femoral vein for
later administration of treatments.
A 7.5-French pulmonary artery catheter (Swan-Ganz;
Edwards Lifesciences, Irvine, CA, USA) was surgically
introduced into the right internal jugular vein and advanced
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under continuous pressure recording into wedge position.
Cardiac output was determined by bolus pulmonary artery
thermodilution (Vigilance monitor; Edwards Lifesciences).
All catheters and pressure transducers were filled with
isotonic saline containing heparin (5 U/ml) and connected
to a multiparametric data collection system (IntelliVue
MP50 monitor; Philips Healthcare, Best, the Netherlands).
The heart rate (HR), right atrial pressure (RAP), mean
pulmonary artery pressure (MPAP), pulmonary artery
occlusion pressure (PAOP) and central body temperature
were also continuously monitored with the IntelliVue
MP50 monitor.
The cardiac index (CI) was calculated to normalise the
data for body surface area in square metres by using a
conversion factor appropriate for pigs (k × BW2/3, where
k =0.09) [24]. Systemic vascular resistance index
(SVRI), pulmonary vascular resistance index (PVRI),
left ventricular stroke work index (LVSWI), right ven-
tricular stroke work index (RVSWI), stroke volume
index (SVI), systemic oxygen delivery index (DO2I),
systemic oxygen consumption (VO2I) and systemic oxygen
extraction ratio (O2ER) were calculated using standard
formulae [25].
Arterial and mixed venous blood were sampled at
each time point for blood gas analysis, including
measurement of haemoglobin (Hb), lactate, sodium
(Na+) and potassium (K+) ion levels (ABL 555 blood gas
meter; Radiometer, Copenhagen, Denmark).
Two burr holes of 5-mm diameter each were placed over
the right and left coronal sutures (12-mm paramedian). In
the right hemisphere, an intraparenchymal probe was
inserted into the cerebral cortex (15-mm depth) and
secured with a single lumen bolt for measurement of
PbtO2 (Neurovent-PTO; RAUMEDIC, Helmbrechts,
Germany). On the left side, a fibre-optic probe (Codman
ICP EXPRESS Monitoring System; Codman Neuro,
Raynham, MA, USA) was inserted epidurally for con-
tinuous monitoring of ICP after sealing the cranial
window with bone wax. CPP was calculated using a
standard formula (CPP =MAP − ICP) [6].
Experimental design
Following surgical preparation, animals were allowed to
stabilise for 30 minutes before being randomly divided
into one of the following four groups: (1) a sham group
(n =6) consisting of animals that were not subjected to
haemorrhagic shock, (2) a HAEMO group (n =12) that
was subjected to haemorrhagic shock and did not receive
treatment, (3) a LR group (n =14) that was subjected to
haemorrhagic shock and treated with LR (volume equal to
three times the volume bled) and (4) a TERLI group
(n =14) that was subjected to haemorrhagic shock and
treated with terlipressin (2-mg bolus of GLYPRESSIN;
Ferring Pharmaceuticals, São Paulo, Brazil).
Randomisation was previously performed, and the blind
allocation of the pigs among groups was placed in
numbered manila envelopes, which were opened in a
consecutive manner immediately before baseline mea-
surements were registered.
Haemorrhagic shock was induced by pressure-controlled
bleeding targeting a MAP of 40 mmHg, which was main-
tained for 30 minutes before treatment. Data were recorded
prior to blood removal (baseline), at 30 minutes after
achieving the target MAP (shock) and at 5 minutes (T5),
30 minutes (T30) and 60 minutes (T60) after treatment. In
some of these animals (sham group: n =3; HAEMO group:
n =9; LR group: n =9; TERLI group: n =9), the study was
continued for 1 additional hour, allowing data to be
registered at 90 minutes (T90) and 120 minutes
(T120) posttreatment. At the end of the study, the
animals were killed with an overdose of isoflurane
and potassium chloride. The intraparenchymal probe
then was macroscopically inspected for insertion
depth, and cortical samples of the brain were collected
and immediately frozen in liquid nitrogen and stored at
−80°C for later analysis.
Preparation of cerebral samples for Western blotting
assays and thiobarbituric acid reactive substance
measurement
The samples were homogenized in ice-cold solution
(200 mM mannitol, 80 mM 4-(2-hydroxyethyl)piperazine-
1-ethanesulfonic acid, 41 mM KOH, pH 7.5) containing a
protease inhibitor cocktail (Sigma-Aldrich, St Louis,
MO, USA) using a POLYTRON PT 10–35 homogenizer
(KINEMATICA, Lucerne, Switzerland). The homogenates
were centrifuged at 4,000 × g for 30 minutes at 4°C to re-
move cell debris. Protein concentrations were determined
by the Bradford assay method using a Bio-Rad protein
assay kit (Bio-Rad Laboratories, Hercules, CA, USA).
Western blotting
Western blotting assays were performed to assess the
expression of the following proteins: AQP4, NKCC1,
Bcl-x, Bax and MnSOD. Cerebral tissue samples were
run on 12% polyacrylamide minigels for AQP4, Bax, Bcl-x
and MnSOD and on 8% polyacrylamide minigels for
NKCC1. After transfer by electroelution to polyvinylidene
fluoride membranes (Amersham Hybond-P; GE Healthcare
Life Sciences, Little Chalfont, UK), blots were blocked with
5% non-fat milk and 0.1% Tween 20 in Tris-buffered saline
for 1 hour. Blots were then incubated overnight with an
anti-AQP4 antibody (1:2,000), NKCC1 (1:500), Bcl-x anti-
body (1:500), Bax antibody (1:500) and MnSOD antibody
(1:200). The labelling was visualised with a horseradish
peroxidase-conjugated secondary antibody (anti-rabbit
immunoglobulin G (IgG), diluted 1:2,000; anti-goat IgG,
diluted 1:10,000; anti-mouse IgG diluted 1:2,000; or
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anti-mouse IgG, diluted 1:2,000, respectively; Sigma-
Aldrich) using an enhanced chemiluminescence (ECL)
detection system (Amersham ECL Western Blotting
Detection kit; GE Healthcare Life Sciences). The ECL
membranes were scanned using Alliance 4.2 (UVItec,
Cambridge, UK), and the cerebral AQP4, NKCC1, Bcl-x
and Bax protein expression levels were quantified using
densitometry, normalizing the bands to actin expression.
Thiobarbituric acid assay
To assess the levels of TBARS, a 0.2-ml cortical cerebral
homogenate sample was diluted in 0.8 ml of distilled
water, followed by addition of 1 ml of 17.5%
trichloroacetic acid. Then, 1 ml of 0.6% thiobarbituric
acid, pH 2, was added to the sample and placed in a
boiling-water bath for 15 minutes. After the sample
was allowed to cool, 1 ml of 70% trichloroacetic acid was
added and the mixture was incubated for 20 minutes. The
sample was then centrifuged at 2,000 × g for 15 minutes.
The absorbance was recorded at 534 nm using a spectro-
photometer, and values were calculated by using a molar
extinction coefficient of 1.56 × 105 M/cm. The TBARS
levels were then normalised to the total protein concen-
tration, and the results are expressed as nanomoles per
gram of protein.
Statistical analysis
Physiological and neuromonitoring parameters and
arterial and mixed venous blood gas data were analysed
(GraphPad Prism version 5.03 for Windows; GraphPad
Software, La Jolla, CA, USA) across groups and time
using two-way analysis of variance (ANOVA) tests.
Tukey’s tests were used for post hoc analysis. Analyses of
survival were performed according to the Kaplan–Meier
method and compared using Fisher’s exact test. The last
observation carried forward imputation method was
applied throughout the study for the animals that
died. Differences in the expression levels of AQP4,
NKCC1, Bcl-x, Bax, MnSOD and TBARS were ana-
lysed by one-way ANOVA followed by the Student-
Newman-Keuls test, and the results are presented as
mean ± standard error. For all analyses, P <0.05 was
considered statistically significant.
Results
The blood volume withdrawn from each group was similar,
averaging 60% of the estimated blood volume (HAEMO
group: 1,083 ± 124 ml; LR group: 1,162 ± 203 ml; TERLI
group: 1,011 ± 215 ml). In the HAEMO group, the number
of deaths following haemorrhage was significantly higher
at 120 minutes (six deaths at 41 ± 15 minutes after shock;
P =0.0007). At 120 minutes after shock, one animal from
the TERLI group had died (at 80 minutes after shock)
(Figure 1).
Haemodynamics
HR was significantly increased in the HAEMO, LR and
TERLI groups from the time of shock to T120 compared
with the sham group (P <0.001). From T30 to T120, HR
was significantly lower in the LR group than in the
HAEMO group (P <0.05) (Figure 2). MAP was signifi-
cantly decreased at shock in all study groups compared
with the sham group (P <0.001). In the HAEMO group,
the MAP was significantly decreased from T5 to T120
compared with the other groups (P <0.001). Compared
with sham animals, MAP was significantly decreased at
T60, T90 and T120 in the LR group (P <0.001) and
at T5 in the TERLI group (P <0.001). No significant
differences in this variable were observed from T30
to T120 between the LR and TERLI groups (Figure 2).
The CI was significantly decreased from T5 to T120
in the HAEMO and TERLI groups compared with
the sham group (P <0.01). At the corresponding time
points, the CI was significantly higher in the TERLI
group than in the HAEMO group (P <0.05). In the
LR group, CI was higher than in the HAEMO and
TERLI groups (P <0.05) (Figure 2).
RAP was significantly decreased (P <0.001) and SVRI
and PVRI were significantly increased (P <0.01) from
shock to T120 in the HAEMO and TERLI groups
compared with the sham group (P <0.01), whereas no
significant differences were observed in these variables
from T5 to T120 between the LR and sham groups.
MPAP was significantly decreased in all groups from
T5 to T120 compared with the sham group (P <0.05)
(Figure 2 and Table 1). In all study groups, PAOP
was significantly decreased at shock compared with
the sham group. In the LR group, PAOP was significantly
increased at T5 and T120 compared with the HAEMO
group at these corresponding time points (Table 1). LVSWI,
Figure 1 Percent survival at 120 minutes after haemorrhagic
shock using the Kaplan–Meier curve. Rats treated with lactated
Ringer’s solution (LR) and terlipressin (TERLI) after haemorrhagic
shock were compared with the non-treated rats (HAEMO) and a
sham group that was not subjected to bleeding. *P =0.0007 indicates
significant difference compared with the sham group.
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Figure 2 Effects of terlipressin and lactated Ringer’s solution in a porcine model of haemorrhagic shock. LR, Rats treated with lactated
Ringer’s solution after haemorrhagic shock; TERLI, Rats treated with terlipressin after haemorrhagic shock; HAEMO, Non-treated rats; Sham, Rats
not subjected to bleeding; PbtO2, Brain tissue oxygen tension; CPP, Cerebral perfusion pressure; ICP, Intracranial pressure; MAP, Mean arterial pressure;
HR, Heart rate; CI, Cardiac index; SRVI, Systemic resistance vascular index; Hb, Arterial haemoglobin level; O2ER, Oxygen extraction ratio; SvO2, Mixed
venous oxygen saturation; BE, Base excess. Data are expressed as mean ± standard error. *P <0.05 versus sham group. †P <0.05 versus HAEMO
group. ‡P <0.05 versus LR group.
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RVSWI and SVI were significantly decreased in the LR and
TERLI groups compared with the sham group (P <0.01)
and significantly increased in the HAEMO group,
compared with the sham group (P <0.01) (Table 1).
Blood gases, oxygenation and electrolytes
pH, HCO3
−, BE, SvO2 and DO2I were significantly
decreased, and O2ER, arterial lactate and K
+ were
significantly increased, from shock to T120 in the
HAEMO, LR and TERLI groups compared with the
sham group (P <0.05) (Table 2). In the LR and TERLI
groups, DO2I was significantly increased from T5 to
T120 and from T30 to T120, respectively, compared
with the HAEMO group (P <0.05). In the LR and
TERLI groups, the VO2I was significantly increased from
T5 to T120 compared with the sham group (P <0.05) and
significantly increased from T30 to T120 compared
with the HAEMO group (P <0.05). The levels of Hb
and Na+ were significantly lower from T5 to T120 in the
LR group compared with the sham group (P <0.05). The
ratio of arterial oxygen partial pressure to fractional
inspired oxygen and the level of PaCO2 did not change
Table 1 Effects of haemorrhagic shock on haemodynamics at baseline, shock and at 5, 30, 60, 90 and 120
posttreatment
Baseline Shock After treatment (min)
5 30 60 90 120
RAP (mmHg)
Sham 8 ± 1 9 ± 2 8 ± 1 8 ± 1 9 ± 1 7 ± 1 6 ± 0
HAEMO 7 ± 2 2 ± 1* 2 ± 1* 2 ± 1* 2 ± 1* 2 ± 1* 2 ± 1*
LR 7 ± 1 2 ± 1* 8 ± 2† 7 ± 2† 6 ± 2*† 5 ± 2† 5 ± 2†
TERLI 7 ± 2 2 ± 1* 2 ± 1*‡ 3 ± 1*‡ 3 ± 1*‡ 2 ± 1*‡ 2 ± 1*‡
MPAP (mmHg)
Sham 19 ± 1 20 ± 1 20 ± 1 20 ± 1 20 ± 1 18 ± 1 18 ± 3
HAEMO 20 ± 3 16 ± 2* 17 ± 3* 17 ± 3* 17 ± 4* 16 ± 2* 16 ± 2*
LR 19 ± 2 17 ± 2* 22 ± 5*† 20 ± 4† 19 ± 3† 19 ± 2† 19 ± 2†
TERLI 20 ± 1 16 ± 2* 18 ± 3†‡ 18 ± 3† 18 ± 2† 19 ± 2† 19 ± 2†
PAOP (mmHg)
Sham 12 ± 1 11 ± 2 11 ± 2 11 ± 1 11 ± 2 9 ± 1 11 ± 2
HAEMO 11 ± 1 8 ± 2* 8 ± 2* 8 ± 1* 8 ± 1* 7 ± 1* 7 ± 1*
LR 11 ± 1 9 ± 2* 11 ± 2† 10 ± 2 9 ± 2 9 ± 2 10 ± 2†
TERLI 11 ± 1 8 ± 1* 8 ± 2 9 ± 1 9 ± 1 9 ± 1 9 ± 1
LVSWI (g-m/m2/beat)
Sham 30 ± 7 35 ± 13 35 ± 10 35 ± 11 33 ± 6 32 ± 6 29 ± 5
HAEMO 34 ± 6 4 ± 1* 3 ± 1* 3 ± 1* 3 ± 1* 3 ± 1* 3 ± 1*
LR 35 ± 4 4 ± 1* 19 ± 3*† 15 ± 4*† 14 ± 4*† 13 ± 4*† 12 ± 4*†
TERLI 37 ± 7 4 ± 1* 8 ± 2*† 10 ± 3*† 10 ± 3*† 9 ± 3*† 8 ± 4*†
RVSWI (g ×m/m2/beat)
Sham 6 ± 0 7 ± 1 6 ± 1 6 ± 1 5 ± 1 7 ± 6 ± 0
HAEMO 7 ± 1 2 ± 0* 2 ± 0* 1 ± 0* 1 ± 0* 1 ± 0* 1 ± 0*
LR 7 ± 1 2 ± 0* 6 ± 2*† 5 ± 2*† 5 ± 2*† 5 ± 1*† 5 ± 1*†
TERLI 8 ± 1 2 ± 1* 3 ± 1*† 3 ± 0*† 3 ± 1*† 3 ± 0*† 3 ± 1*†
SVI (ml/beat/m2)
Sham 44 ± 11 40 ± 11 38 ± 11 39 ± 13 41 ± 8 41 ± 9 38 ± 11
HAEMO 42 ± 6 8 ± 2* 8 ± 2* 7 ± 1* 7 ± 1* 7 ± 1* 7 ± 1*
LR 43 ± 4 8 ± 1* 28 ± 4*† 25 ± 5*† 24 ± 6*† 24 ± 6*† 23 ± 6*†
TERLI 47 ± 7 9 ± 1* 12 ± 3* 13 ± 2*† 13 ± 2*† 13 ± 3*† 13 ± 3*†
LR, Rats treated with lactated Ringer’s solution after haemorrhagic shock; TERLI, Rats treated with terlipressin after haemorrhagic shock; HAEMO, Non-treated rats;
Sham, Rats not subjected to bleeding; RAP, Right atrial pressure; MPAP, Mean pulmonary artery pressure; PAOP, Pulmonary artery occlusion pressure; LVSWI, Left
ventricular stroke work index; RVSWI, Right ventricular stroke work index; SVI, Stroke volume index. *P <0.05 versus sham group. †P <0.05 versus HAEMO group.
‡P <0.05 versus LR group.
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significantly in any group during the study (Figure 2
and Table 2).
Neuromonitoring
CPP, ICP and PbtO2 were significantly decreased from
shock to T60 in the HAEMO group compared with the
sham animals (P <0.05). Both treatments with LR and
TERLI were followed by a significant increase in CPP
compared with the HAEMO group (P <0.01), with CPP
recovering to values not significantly different from those
of the sham group. The LR group had the largest increase
in ICP, which was observed from T5 to T120 (P <0.05
versus sham; P <0.001 versus HAEMO group; P <0.001 ver-
sus TERLI group). The TERLI group had no significant dif-
ferences in ICP from T30 to T120 compared with the sham
group. Treatments with LR and TERLI recovered PbtO2 to
values similar to those in the sham group (Figure 2).
Aquaporin-4 and Na+-K+-2Cl− co-transporter
At 60 minutes after shock, semiquantitative immunoblot
analysis revealed a significant increase in the expression
of AQP4 in the HAEMO group (179 ± 12% of sham,
P =0.0086), which was not reversed by treatment with
LR (196 ± 8% of sham, P =0.0047), but was fully restored
by TERLI (125 ± 6% of sham). In the TERLI group, the
expression of AQP4 was significantly higher at 60 minutes
compared with the HAEMO and LR groups (P =0.0071).
At 120 minutes, a significant upregulation of AQP4
was observed only in the LR group (217 ± 37% of
sham, P =0.0084), which was significantly higher than in
TERLI group (117 ± 19% of sham, P =0.0169) (Figure 3).
No significant increase in the expression of NKCC1
was observed in any group at 60 minutes after shock,
but NKCC1 expression was significantly increased at
120 minutes in the HAEMO group (237 ± 47% of sham,
Table 2 Effects of haemorrhagic shock on blood gases, oxygenation and electrolytes at baseline, shock and at 5, 30,
60, 90 and 120 minutes posttreatment
Baseline Shock After treatment (min)
5 30 60 90 120
PaCO2 (mmHg)
Sham 47 ± 0 43 ± 3 41 ± 2 42 ± 1 42 ± 0 40 ± 0 41 ± 1
HAEMO 42 ± 3 39 ± 4 35.6 ± 7* 43 ± 8 38 ± 6 38 ± 8 38 ± 8
LR 42 ± 4 38 ± 4 42.3 ± 3 41 ± 3 40 ± 2 39 ± 2 39 ± 2
TERLI 43 ± 2 42 ± 4 42.9 ± 5† 47 ± 6† 48 ± 7† 45 ± 4† 44 ± 5
DO2I (ml/min/m
2)
Sham 540 ± 2 571 ± 107 501 ± 105 522 ± 108 553 ± 64 543 ± 95 518 ± 131
HAEMO 597 ± 81 243 ± 52* 212 ± 64* 190 ± 37* 192 ± 38* 194 ± 46* 190 ± 37*
LR 580 ± 61 237 ± 73* 400 ± 49*† 375 ± 62*† 361 ± 66*† 344 ± 64*† 339 ± 59*†
TERLI 581 ± 96 238 ± 27* 288 ± 19* 307 ± 43*† 313 ± 51*† 302 ± 55*† 299 ± 73*†
VO2I (ml/min/m
2)
Sham 121 ± 3 140 ± 17 126 ± 28 133 ± 13 139 ± 9 133 ± 21 143 ± 24
HAEMO 126 ± 27 154 ± 36 139 ± 40 119 ± 20 123 ± 39 126 ± 27 122 ± 21
LR 129 ± 33 152 ± 38 173 ± 37* 176 ± 24*† 182 ± 30*† 178 ± 24*† 187 ± 33*†
TERLI 123 ± 19 152 ± 21 161 ± 8* 174 ± 22*† 176 ± 23*† 172 ± 23*† 170 ± 24*†
K+ (mmol/L)
Sham 4.4 ± 0.3 4.3 ± 0.0 4.0 ± 0.1 4.3 ± 0.1 4.4 ± 0.1 4.4 ± 0.5 4.5 ± 0.3
HAEMO 4.3 ± 0.4 5.6 ± 0.9* 5.2 ± 0.9 5.7 ± 0.9* 5.8 ± 0.8* 6.0 ± 0.6* 6.2 ± 0.5*
LR 3.9 ± 0.2 5.8 ± 1.5* 4.0 ± 0.3† 4.4 ± 0.4† 4.9 ± 0.6*† 5.2 ± 0.7* 5.1 ± 1.1*
TERLI 4.2 ± 0.2 5.3 ± 0.5* 5.4 ± 0.5* 5.0 ± 0.5 5.2 ± 0.5* 5.3 ± 0.6* 5.5 ± 0.7*
Na+ (mmol/L)
Sham 140 ± 1 140 ± 0 142 ± 1 140 ± 3 141 ± 1 139 ± 3 139 ± 1
HAEMO 139 ± 3 137 ± 2 137 ± 3 137 ± 2 137 ± 2 137 ± 2 136 ± 2
LR 141 ± 2 138 ± 4 137 ± 3 137 ± 3* 136 ± 2* 135 ± 3* 135 ± 2*
TERLI 140 ± 3 139 ± 3 137 ± 2 138 ± 3 138 ± 3 139 ± 3 139 ± 5
LR, Rats treated with lactated Ringer’s solution after haemorrhagic shock; TERLI, Rats treated with terlipressin after haemorrhagic shock; HAEMO, Non-treated rats;
Sham, Rats not subjected to bleeding; PaCO2, Partial pressure of dioxide carbon in the arterial blood; DO2I, Oxygen delivery index; VO2I, Oxygen consumption
index; K+, Potassium ion levels; Na+, Sodium ion levels. *P <0.05 versus sham group. †P <0.05 versus HAEMO group.
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P =0.0234), which was fully restored by treatment with
terlipressin (100 ± 1% of sham, P =0.0270) (Figure 3).
Manganese superoxide dismutase and thiobarbituric acid
reactive substances
The levels of TBARS were not significantly different
from the sham group in any study group at 60 minutes
after shock. However, at 120 minutes after shock,
these levels were clearly higher in the HAEMO group
(0.38 ± 0.05 nmol/mg of protein; P =0.0013) and LR
group (0.31 ± 0.10 nmol/mg of protein; P =0.0167), but
not in the TERLI group (0.14 ± 0.01 nmol/mg of protein)
compared with the sham group (0.03 ± 0.01 nmol/mg of
protein). At 120 minutes after shock, the levels of TBARS
in the TERLI group were significantly lower than in the
HAEMO group (P <0.0001) and the LR group (P =0.0394)
(Figure 4). Animals treated with LR had the highest
expression of MnSOD at 60 minutes after shock
(245 ± 11% of sham, P <0.0001), whereas no significant
changes in the expression of MnSOD were observed in the
other groups at the corresponding time point (HAEMO
group: 157 ± 10% of sham; TERLI group: 125 ± 5% of
sham). At 120 minutes after shock, the expression of
MnSOD was significantly increased in the HAEMO group
(237 ± 14% of sham, P =0.0081), which was not reversed
by LR (244 ± 9% of sham, P =0.0009), but it was fully
restored by TERLI (105 ± 16% of sham) (Figure 4).
Bax and Bcl-x
The antiapoptotic Bcl-x protein was significantly upreg-
ulated at 60 and 120 minutes after shock in the TERLI
group (60 minutes: 197 ± 17% of sham, P =0.0038;
120 minutes: 261 ± 48% of sham, P =0.0033), but not in
the HAEMO group (60 minutes: 122 ± 6% of sham;
120 minutes: 32 ± 8% of sham) or LR group (60 minutes:
92 ± 7% of sham; 120 minutes: 67 ± 18% of sham)
(Figure 5). The proapoptotic Bax protein was markedly
upregulated at 60 and 120 minutes in the HAEMO
group (60 minutes: 347 ± 46% of sham, P =0.0088;
120 minutes: 190 ± 31% of sham, P =0.0154) and LR
group (60 minutes: 339 ± 28% of sham, P =0.0021;
120 minutes: 154 ± 16% of sham, P =0.0129), signifi-
cantly higher than the TERLI group (Figure 5). The
Bcl-x/Bax ratio was significantly decreased at 60 minutes
after shock in the HAEMO group (0.26 ± 0.03, P =0.0002)
and LR group (0.20 ± 0.02, P <0.0001) compared with
the sham group (1.00 ± 0.05). At the corresponding
time, animals treated with TERLI had a Bcl-x/Bax
ratio (0.77 ± 0.19) significantly higher than that of the
HAEMO group (P =0.0393) and LR group (P =0.0235).
At 120 minutes after shock, the Bcl-x/Bax ratio was
significantly higher in the TERLI group (2.40 ± 0.46)
than in the HAEMO group (0.17 ± 0.05, p =0.0098)
and LR group (0.40 ± 0.08, P =0.0054), but not with
that in the sham group (1.00 ± 0.44) (Figure 5).
Figure 3 Semiquantitative immunoblotting of membrane fractions prepared from cerebral samples. A densitometric analysis for the
expression of aquaporin-4 (AQP4) and Na+-K+-2Cl− co-transporter (NKCC1) in samples from the sham, HAEMO, LR and TERLI groups is shown.
Immunoblots reacted with anti-AQP4 revealed a 34 kDa band, and those reacted with anti-NKCC1 revealed a 135 to 170 kDa band. Data are
expressed as mean ± standard error. *P <0.05 versus sham group. †P <0.05 versus HAEMO group. ‡P <0.05 versus LR group.
Ida et al. Critical Care  (2015) 19:107 Page 8 of 14
Discussion
Haemorrhagic shock can result in global cerebral
hypoxia caused by hypovolaemia and hypotension,
and the haemodynamic resuscitation must restore
CPP in order to prevent ischaemic injury within the
brain [6-8,26]. The results of the present study indicate
that early treatment with terlipressin can recover CPP
after haemorrhagic shock and that the underlying
mechanisms include regulation of water and Na+ channels,
inhibition of oxidative stress and decrease of apoptotic
signalling within the brain. Survival times were similar at
120 minutes after haemorrhagic shock among groups, with
the exception of the HAEMO group. However, whereas
therapy with TERLI provided superior outcomes than LR
with regard to measures of cerebral damage, it provided
inferior outcomes with regard to systemic or peripheral
measures of haemodynamics and tissue perfusion.
As expected, CPP was not preserved at a blood pressure
below the cerebral autoregulation threshold [27], which
was followed by reduction in PbtO2 [8,28,29]. In the
Figure 4 Changes in the level of thiobarbituric acid reactive substances and expression of manganese superoxide dismutase from
cerebral samples from the sham, HAEMO, LR and TERLI groups. (a) Each bar represents the group mean ± standard error. (b) Immunoblots
reacted with antibody against manganese superoxide dismutase revealing a 24 kDa band. *P <0.05 versus sham group. †P <0.05 versus HAEMO
group. ‡P <0.05 versus LR group. HAEMO, No-treatment group; LR, Lactated Ringer’s solution group; TERLI, Terlipressin group.
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non-treated animals, these derangements were associated
with upregulation of AQP4 and NKCC1. These proteins
play an important role in the formation of cellular oedema
in the brain by regulating water and Na+ transport
through the sealing junctions of the blood–brain barrier
in response to cerebral ischaemia [10,30-32]. AQP4 acts
by increasing water transport mainly in the pericapillary foot
process of astrocytes [9], and NKCC1 acts by increasing
secretion of Na+, Cl− and water through an intact
blood–brain barrier into the brain [10]. Therefore, it was
suggested that cerebral hypoperfusion was followed by
ischaemic lesions in the HAEMO group. Cerebral hypo-
perfusion might have contributed to an accumulation of
lipid peroxidation products, as reflected by the increased
levels of TBARS, which might induce a compensatory
increase in the expression of MnSOD [12,33,34]. Oxygen
free radicals exert their pathophysiologic effects by directly
attacking lipids and proteins in the biologic membranes,
which can cause cellular dysfunction and induce apoptotic
cell death [35]. Indeed, in the present study, the exposure
of the brain to a high level of oxidative stress following
haemorrhagic shock was associated with a marked shift in
the Bcl-x/Bax ratio, indicating a loss of antiapoptotic abil-
ity [36]. Bcl-x and Bax are proteins that play an important
role in determining the relative sensitivity of neuronal
subpopulations to ischaemia. Accordingly, previous
studies showed that haemorrhagic shock can induce a
significant oxidative stress in the brain [12,37] and that
cerebral ischaemia can decrease the Bcl-x/Bax ratio [38].
Furthermore, other markers of cerebral cellular damage
Figure 5 Semiquantitative immunoblotting of membrane fractions prepared from cerebral samples. A densitometric analysis for the
expression of Bax and Bcl-x in samples from the sham, HAEMO, LR and TERLI groups is shown. Immunoblots reacted with pro- and antiapoptotic
Bax and Bcl-x proteins revealed 23 kDa and 26 kDa bands, respectively. Data are expressed as mean ± standard error. *P <0.05 versus sham group.
†P <0.05 versus HAEMO group. ‡P <0.05 versus LR group. HAEMO, No-treatment group; LR, Lactated Ringer’s solution group; TERLI,
Terlipressin group.
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have also been described following haemorrhagic shock
in other studies, such as an increased level of glycerol in
brain tissue [26] and increased plasma levels of S100B [7],
findings which support the presently reported results.
The direct vasoconstrictive effect of terlipressin, reflected
by increased MAP and SRVI, prevented an improvement in
CI but probably allowed for the redistribution of blood flow
towards the cerebral circulation, leading to the restoration
of CPP and PbtO2. Some effects cannot be differentiated
from the common properties of any vasopressor, but it has
been suggested that terlipressin can induce a selective
vasoconstrictor effect according to the distribution of
V1 vasopressin receptors. This hypothesis is supported by
previous studies in which researchers used norepinephrine
in models of haemorrhagic shock, which did not improve
CPP or oxygenation [39,40]. Furthermore, another study
showed that vasopressin, the natural terlipressin analogue,
resulted in a significantly higher increase of CPP com-
pared with norepinephrine [41]. As with the TERLI group,
an increased SRVI was also found in non-treated animals;
however, this was not accompanied by an increase in
MAP in the HAEMO group. The increase in MAP could
have restored the cerebral autoregulation in animals
treated with terlipressin, which might explain the recovery
in CPP and PbtO2. Another explanation for the recovery
in CPP is the higher PaCO2 compared with the HAEMO
group. Because PaCO2 has a linear positive correlation
with cerebral blood flow [42], it could account for more
cerebral vasodilation and hence better perfusion com-
pared with non-treated animals. However, it was unclear
whether terlipressin also acted directly via V1 vasopressin
receptors within the brain [43], which might also explain
the recovery in ICP and, in turn, CPP. Moreover, the ex-
pression levels of both AQP4 and NKCC1 were also re-
stored in animals treated with terlipressin, which also
supports the finding that cerebral perfusion was recov-
ered. Despite the increase in SRVI, the fact that lactate,
O2ER and SvO2 were not significantly different between
groups suggests that terlipressin did not impair periph-
eral perfusion compared with the HAEMO group. In
fact, BE was less negative in the TERLI group. However,
compared with the treatment with LR, terlipressin re-
sulted in inferior outcomes with regard to measures
of haemodynamics such as CI, RAP, SVRI and PVRI,
which might explain the death of one animal in the
TERLI group.
As with the present data, an improvement in CPP has
also been described in patients with persistent arterial
hypotension and acute liver failure [17], traumatic brain
injury [23] and septic shock [22] who were successfully
treated with terlipressin. In the present study, systemic
hypoperfusion could have accounted for unreleased, and
thus undetected, products of oxidative stress within the
brain, which could have caused cell damage. However, if
that was the case, then PbtO2 would not have recovered,
unless mitochondria were incapable of using oxygen,
allowing an increased availability of oxygen within the
tissue. As mitochondrial function was not assessed in
the present study, this explanation remains speculative.
Also, oxidative damage would probably be associated
with inflammation, but this was not supported by a
previous study in which researchers found an improved
inflammatory cytokine profile in rats treated with ter-
lipressin compared with LR [14]. Nonetheless, the
outcome was associated with an increase in the Bcl-x/Bax
ratio, suggesting that if any cerebral oxidative injury or
ischaemia were present, it probably was not sufficiently
severe to trigger antiapoptotic signalling [36,38] within the
brain in terlipressin-treated animals.
Treatment with LR, however, was followed by a
discrepancy between the increments in PbtO2 that was
not accompanied by recovery of CPP. This discrepancy can
be attributed to the systemic third-spacing of crystalloids,
which would also be consistent with the decline in MAP
over the course of 120 minutes [14]. This explanation is
supported by the overexpression of AQP4 in the LR group,
which might indicate a compensatory mechanism to
eliminate excess water within the brain water [44].
An increase in brain water content can also explain
the increase in ICP, which, in turn, is detrimental to
the restoration of CPP. This finding is also in line
with the decreased blood Na+ levels in the group
treated with LR compared with the sham group.
Another hypothesis is that a decrease in blood viscosity
after intravascular volume expansion, despite some differ-
ences in ICP, could increase cerebral blood flow [45] and
thus explain the similar PbtO2 values between LR and
TERLI groups. The LR group had the largest increase in
ICP, but whether it induced overexpression of the brain
tissue markers of water balance, oxidative stress and
apoptosis is unknown. The fact is that regardless of
the mechanism(s) underlying the failure of full recovery of
CPP in the LR group, it remains the case that the markers
of oxidative stress, TBARS and MnSOD, were overex-
pressed in animals treated with LR. The fluid infusion could
have carried the overproduction of reactive oxygen species
(ROS) throughout the tissue initiating a postischaemic
reperfusion injury [36,46,47]. ROS regulate mechanisms via
inflammatory pathways that ultimately can decrease vascu-
lar resistance [35], allowing for an increase in brain volume
that could be partly responsible for unrecovered CPP in the
LR group. In fact, researchers in a previous study found an
increased proinflammatory cytokine profile and severe
hypotension (40 mmHg) in rats treated with LR after
haemorrhagic shock [14]. This oxidative stress could have
reduced the antiapoptotic trend of the Bcl-x/Bax ratio in
the brain during postischaemic reperfusion [36,38]. These
alterations in the expression of Bcl-x and Bax may indicate
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that mitochondria were dysfunctional, as these proteins are
part of the intrinsic mitochondria-related apoptotic
pathway. Therefore, similar to the considerations pre-
viously described for the terlipressin-treated animals,
one hypothesis is that an increased PbtO2 could have
been caused by an increased availability of oxygen because
dysfunctional mitochondria are not capable of using the
oxygen available in the tissue.
Some limitations of this study should be noted. First is
the short observation time, which we used because the
experiment was designed to determine the early cerebral
effects observed during prehospital care, rather than to
determine long-term functional neurologic outcome or
correlation to brain histopathology. Second, PbtO2 was
measured locally with a probe placed in the cerebral cortex,
and therefore global ischaemia caused by a heterogeneous
distribution of PbtO2 may have been underestimated with
regard to the brain region analysed. Third, cerebral blood
flow was not measured, because the purpose of the present
study was to evaluate changes in CPP and oxygenation.
Also, the anaesthetics used may be cerebroprotective and
may have different effects in ICP and MAP, but these were
minimised by having a sham group and another group not
treated after haemorrhagic shock, which were both sub-
jected to the same anaesthetic protocol as the treated
groups. In addition, some varieties caused by different vaso-
pressin receptors in pigs (lysine vasopressin) and humans
(arginine vasopressin) might have resulted in a different
haemodynamic response to terlipressin. However, these
differences do not interfere with the results of our study,
because the study was aimed at investigating differences
between groups and changes over time rather than
presenting absolute values. Finally, we used only terlipres-
sin as a vasopressor, and therefore we are unable to report
whether different vasopressors would have yielded other
results.
Conclusions
Early treatment with terlipressin was effective at restoring
CPP and preventing dysregulation of water balance,
and oxidative and apoptotic markers within the brain,
following haemorrhagic shock in our model. These
results indicate that the role of this pressor agent on
brain perfusion in haemorrhagic shock requires further
investigation.
Key messages
 Early treatment with terlipressin recovered cerebral
perfusion pressure and brain tissue oxygen tension
after haemorrhagic shock in pigs.
 Terlipressin was effective for normalising cerebral
markers of water balance, oxidative damage and
apoptosis after haemorrhagic shock.
 These cerebral improvements were observed for at
least 2 hours after haemorrhagic shock in animals
treated with terlipressin.
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